Navigation Links
SAIC-Frederick and Biomatrica Collaborate to Improve Molecular Analysis in Cancer Research
Date:5/31/2011

FREDERICK, Md., May 31, 2011 /PRNewswire/ -- SAIC-Frederick, Inc. and Biomatrica have begun a technology collaboration to improve molecular analysis of tumors, which is becoming increasingly important in cancer research and in the design of the next generation of targeted therapies.

The two organizations will focus on developing better processes to isolate nucleic acids from tumor samples collected by pathologists in the clinic. Preserving nucleic acids, particularly RNA, is important for correlating histology of tumor tissues and molecular analysis. Traditional methods for preserving these nucleic acids are not well adapted to the clinical setting, however, so their usefulness in research has been limited.

The collaboration was developed under the Advanced Technology Partnerships Initiative (ATPI) of the National Cancer Institute (NCI). SAIC-Frederick is the operations and technical support contractor for NCI's federal national laboratory in Frederick, Md., and facilitates partnerships for the ATPI, which aims to move basic research findings more rapidly into the clinic to benefit patients.

Under the collaboration, SAIC-Frederick researchers at the Laboratory Animal Sciences Program will explore integration of proprietary reagents from Biomatrica into molecular pathology workflows. The objective is to streamline processes while increasing efficiency and integrity of RNA isolated from histological samples in cancer studies.

"Our team continually explores better ways to conduct assays. This collaboration with Biomatrica may improve isolation of nucleic acids from histological samples, particularly very labile RNA molecules," said Larry Sternberg, Ph.D., Director of the Histology Section of the Laboratory Animal Sciences Program. Sternberg is employed by SAIC-Frederick, which operates the facility for NCI.

Conventional RNA isolation from histological samples is typically a low-throughput operation that requires considerable infrastructure and can be too expensive for large- scale studies. The collaboration has the potential to change this paradigm.

"We have developed novel formulations that protect nucleic acids (RNA and DNA) in blood, tissue, cell lines, saliva, biopsy material, etc. at room temperature with comparable or better performance than traditional ultra-cold temperature systems. These products have the added benefits of yielding significant cost savings, improved workflow, higher sample quality, scalability and flexibility," said Dr. Rolf Muller, Biomatrica's President, Chief Scientific Officer and Founder. "We are excited to be partnering with a leading scientific organization such as SAIC-NCI in developing new technologies for better management of critical biological samples in cancer research."

About SAIC-Frederick

SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation (SAIC), a Fortune 500® company, is the operations and technical support contractor for the National Cancer Institute's research and development center in Frederick, Md. This is a national laboratory dedicated to rapidly translating basic research into new technologies for diagnosing, treating, and preventing cancer and AIDS. SAIC-Frederick maintains a full suite of advanced technologies in areas such as nanotechnology, genomics and imaging; operates the federal government's drug and vaccine manufacturing facilities; operates the high-performance Advanced Biomedical Computing Center; and supports more than 300 clinical trials for patients in the United States and around the world. http://www.saic-frederick.com

About Biomatrica

Biomatrica is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing, shipping and assaying biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA and RNA with no sample degradation, thus labs can reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories. Custom services to stabilize additional sample types such as proteins are also available. http://www.biomatrica.com


'/>"/>
SOURCE Biomatrica Inc.; SAIC-Frederick, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. David Heimbrook Appointed Chief Executive Officer of SAIC-Frederick, Inc.
2. Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatricas Room Temperature Storage
3. Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan
4. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
5. Biomatrica Launches SampleWare 3.1
6. Biomatrica Launches New Partnership Program - Biomatrica Connect(TM)
7. Biomatrica Announces the Appointment of Dr. James A. Robb as a Member of the Scientific Advisory Board
8. Cyntellect to Collaborate With the Burnham Institute for Medical Research
9. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
10. Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes
11. Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ... April 20, 2017 , ... Husson University will be ... growing body of knowledge during its Eighth Annual Research and Scholarship Day ... Darling Atrium. During the event, undergraduates, graduate students, and faculty members from all ...
(Date:4/20/2017)... ... April 20, 2017 , ... Parallel6™ , the leader in mClinical™ ... that they were named one of the 2017 Top 10 eClinical Trial Management ... the pharmaceutical industry. , “We take pride in honoring Parallel6 as one of the ...
(Date:4/20/2017)... -- For today, Stock-Callers.com redirects investors, attention to ... clinical research aimed at treating diseases and medical conditions. Under ... Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and ZIOPHARM ... our complimentary research reports on these stocks now at: ... http://stock-callers.com/registration ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced ... comes after the company changed focus to making analytical tools for biopharmaceutical quality ... new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
Breaking Biology News(10 mins):